Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)

NCT03199989 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1254

Enrollment

OTHER

Sponsor class

Conditions

Adjuvant Chemotherapy

Interventions

DRUG: CapeOX（Capecitabine+Oxaliplatin）
OTHER: Observation

Sponsor

Peking University Cancer Hospital & Institute

Collaborators

[object Object]
[object Object]